The estimated Net Worth of Gary Gregory is at least $5.37 Milion dollars as of 31 August 2006. Gary Gregory owns over 36,833 units of Neurometrix stock worth over $125,047 and over the last 19 years Gary sold NURO stock worth over $5,241,000.
Gary has made over 8 trades of the Neurometrix stock since 2005, according to the Form 4 filled with the SEC. Most recently Gary exercised 36,833 units of NURO stock worth $82,874 on 31 August 2006.
The largest trade Gary's ever made was selling 75,000 units of Neurometrix stock on 8 November 2005 worth over $2,620,500. On average, Gary trades about 18,667 units every 18 days since 2005. As of 31 August 2006 Gary still owns at least 31,341 units of Neurometrix stock.
You can see the complete history of Gary Gregory stock trades at the bottom of the page.
Gary's mailing address filed with the SEC is C/O NEUROMETRIX, INC., 62 FOURTH AVENUE, WALTHAM, MA, 02451.
Over the last 20 years, insiders at Neurometrix have traded over $14,886,276 worth of Neurometrix stock and bought 3,074,896 units worth $6,396,868 . The most active insiders traders include James Edeerfield Capital Lp..., Capital Partners, Lp Topline oraz Capital Management, Llc Mc .... On average, Neurometrix executives and independent directors trade stock every 45 days with the average trade being worth of $133,905. The most recent stock trade was executed by Thomas T Higgins on 2 May 2024, trading 498 units of NURO stock currently worth $2,226.
neurometrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. the company maintains an active research effort and has several pipeline programs. the company is located in waltham, massachusetts and was founded as a spinoff from the harvard-mit division of health sciences and technology in 1996. for more information, please visit neurometrix.com. neurometrix markets the following products: quell® wearable pain relief technology™ quell is 100% drug free wearable technology that has changed the lives of people suffering with chronic pain. it combines clinical strength neurostimulation to treat pain with an easy-to-use app that helps people manage pain and reclaim their lives. quell is doctor recommended and designed for people with chronic back pain, arthritic pain, nerve pain, leg and foot pain, among other chronic pain conditions. quell launc
Neurometrix executives and other stock owners filed with the SEC include: